Weigao Group
Weigao Group engages in the research and development, production, export, and sale of medical devices.
Launch date
Employees
Market cap
€2.2b
Enterprise valuation
€1.8b (Public information from Sep 2024)
Share price
HKD4.63 1066.HK
Weihai Shandong (HQ)
Financials
Estimates*
| CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 11.3b | 13.2b | 13.6b | 13.2b | 13.9b | 15.0b | 16.1b |
| % growth | 9 % | 16 % | 4 % | (3 %) | 5 % | 9 % | 7 % |
| EBITDA | 3.3b | 4.0b | 4.4b | 3.6b | 3.4b | 3.6b | 4.2b |
| % EBITDA margin | 29 % | 31 % | 32 % | 27 % | 25 % | 24 % | 26 % |
| Profit | 2.0b | 2.2b | 2.7b | 2.0b | 2.1b | 2.4b | 2.6b |
| % profit margin | 18 % | 17 % | 20 % | 15 % | 15 % | 16 % | 16 % |
| EV / revenue | 5.7x | 2.5x | 3.6x | 2.1x | 0.9x | 0.8x | 0.6x |
| EV / EBITDA | 19.7x | 8.1x | 11.2x | 7.9x | 3.5x | 3.1x | 2.2x |
| R&D budget | 411m | 492m | 547m | 593m | - | - | - |
| R&D % of revenue | 4 % | 4 % | 4 % | 4 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
Recent News about Weigao Group
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
